Skip to main content
Elizabeth Jaffee, MD, Oncology, Baltimore, MD

Elizabeth Marion Jaffee MD

Gastrointestinal Cancer


Professor of Oncology and Professor of Pathology, Johns Hopkins University School of Medicine; The Dana and Albert "Cubby" Broccoli Professor of Oncology; Co-Director, Skip Viragh Center for Pancreas Cancer; Co-Director, Gastrointestinal Cancers Program; Co-Director of the Cancer Immunology Program and the Immunology and Hematopoiesis Division

Join to view full profile
  • 600 N Wolfe StBaltimore, MD 21287

  • Phone+1 410-955-8964

Dr. Jaffee is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
  • UPMC Medical Education
    UPMC Medical EducationInternship, Internal Medicine, 1985 - 1986
  • New York Medical College
    New York Medical CollegeClass of 1985

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1989 - 2026
  • PA State Medical License
    PA State Medical License 1986 - 1990
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology Clinic  
    Mark Yarchoan, Elizabeth Jaffee, Annals of Oncology

Press Mentions

  • Researchers Hope the New Drug Is Just the Beginning, Opening a New Chapter in Treatment for a Range of Cancer Types
    Researchers Hope the New Drug Is Just the Beginning, Opening a New Chapter in Treatment for a Range of Cancer TypesAugust 27th, 2026
  • How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
    How an ‘Impossible’ Idea Led to a Pancreatic Cancer BreakthroughMay 12th, 2026
  • HHS Has a Potential Solution for Cancers That Keep Coming Back: Vaccines
    HHS Has a Potential Solution for Cancers That Keep Coming Back: VaccinesMarch 17th, 2026

Grant Support

  • Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical TrialJOHNS HOPKINS UNIVERSITY2015–2031
  • Targeting HMGA1 Tumor-Stromal Networks in Pancreatic CarcinogenesisJOHNS HOPKINS UNIVERSITY2024–2029
  • Transforming Human Pancreatic Cancer Into An Immunologic DiseaseJOHNS HOPKINS UNIVERSITY2021–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: